Argenx Se (ARGX) Income from Discontinued Operations (2018 - 2025)

Argenx Se (ARGX) posted Income from Discontinued Operations of 129656000.0 for Q4 2025, up 410.22% on a QoQ basis from 41795000.0 in Q3 2025, and down 81.15% year-over-year from 687652000.0 in Q4 2024.

Argenx Se (ARGX) Income from Discontinued Operations (2018 - 2025) Analysis & Trends

Argenx Se's Income from Discontinued Operations history runs 6 years deep, the most recent figure standing at 129656000.0 for Q4 2025.

  • Quarterly Income from Discontinued Operations fell 81.15% year-over-year to 129656000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 96510000.0 (down 87.1% YoY) and the FY2025 annual result came in at 13428000.0, down 98.2% from the prior year.
  • Income from Discontinued Operations was 129656000.0 for Q4 2025 at Argenx Se, up from 41795000.0 in the prior quarter.
  • Across five years, Income from Discontinued Operations topped out at 687652000.0 in Q4 2024 and bottomed at 41795000.0 in Q3 2025.
  • A 5-year average of 49074722.22 and a median of 6522000.0 in 2021 frame the typical range for Income from Discontinued Operations.
  • Annual changes were most pronounced in 2023 — Income from Discontinued Operations sank 1547.39% — and 2024, when it jumped 1909.9%.
  • Argenx Se's Income from Discontinued Operations stood at 7062000.0 in 2021, then sank by 62.83% to 2625000.0 in 2022, then sank by 1547.39% to 37994000.0 in 2023, then soared by 1909.9% to 687652000.0 in 2024, then tumbled by 81.15% to 129656000.0 in 2025.
  • Business Quant data shows ARGX's Income from Discontinued Operations at 129656000.0 in Q4 2025, 41795000.0 in Q3 2025, and 41541000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 129.66 Mn
Sep 30, 2025 -41.80 Mn
Jun 30, 2025 41.54 Mn
Mar 31, 2025 -32.89 Mn
Dec 31, 2024 687.65 Mn
Sep 30, 2024 3.39 Mn
Jun 30, 2024 44.07 Mn
Mar 31, 2024 12.75 Mn
Dec 31, 2023 -37.99 Mn
Sep 30, 2023 10.64 Mn
Jun 30, 2023 -10.51 Mn
Mar 31, 2023 47.31 Mn
Dec 31, 2022 2.63 Mn
Sep 30, 2022 5.98 Mn
Jun 30, 2022 8.23 Mn
Mar 31, 2022 2.89 Mn
Dec 31, 2021 7.06 Mn
Sep 30, 2021 2.75 Mn
Sep 30, 2018 1,163.13